CD22 HEK293
CBP74698
询 价
索取Protocol
产品描述
产品数据库
| I. Background | |
| CD22是一种B细胞特异性的抑制性共受体,属于SIGLEC(唾液酸结合免疫球蛋白样凝集素)家族,主要表达于成熟B细胞表面。它顺利获得胞内ITIM基序招募SHP-1磷酸酶,负向调控B细胞受体(BCR)信号,从而维持B细胞免疫耐受、防止过度活化。CD22也是B细胞淋巴瘤和自身免疫病治疗的重要靶点,相关抗体药物(如依帕珠单抗)和ADC药物正在开发中。 | |
| II. Description | |
| CD22 HEK293 细胞,在 HEK293 细胞的基础上,稳定表达 CD22。 | |
| III. Introduction | |
| Expressed gene: | CD22 |
| Host Cell: | HEK293 |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | DMEM + 10% FBS + 5 μg/ml Blasticidin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Binding Assay,FACS |
| IV. Representative Data | |
Figure 1. Recombinant CD22 HEK293 constitutively expressing CD22. |
|